738 related articles for article (PubMed ID: 2666885)
21. Treatment of galactorrhea-amenorrhea.
De Leon FD
Am Fam Physician; 1985 Dec; 32(6):121-4. PubMed ID: 4072865
[TBL] [Abstract][Full Text] [Related]
22. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
[TBL] [Abstract][Full Text] [Related]
23. High prolactin level.
Piketty ML; Nataf F; Dilouya A; Roux FX
J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
[No Abstract] [Full Text] [Related]
24. Clinical presentation of hyperprolactinemia.
Luciano AA
J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
[TBL] [Abstract][Full Text] [Related]
25. Amenorrhea, galactorrhea, and hyperprolactinemia.
Magyar DM
J Am Osteopath Assoc; 1985 Jun; 85(6):375-80. PubMed ID: 3905728
[No Abstract] [Full Text] [Related]
26. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T
No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy, delivery and lactation in hyperprolactinaemic women.
Sas M; Godó G; Koloszár S
Acta Med Hung; 1986; 43(1):13-22. PubMed ID: 3774415
[TBL] [Abstract][Full Text] [Related]
28. The prolactinoma problem.
Reichlin S
N Engl J Med; 1979 Feb; 300(6):313-5. PubMed ID: 759885
[No Abstract] [Full Text] [Related]
29. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
30. Hyperprolactinemia and reproductive disorders--a profile from north east.
Choudhury SD; Goswami A
J Assoc Physicians India; 1995 Sep; 43(9):617-8. PubMed ID: 8773064
[TBL] [Abstract][Full Text] [Related]
31. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
[TBL] [Abstract][Full Text] [Related]
32. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
[TBL] [Abstract][Full Text] [Related]
33. Hyperprolactinaemia.
Prabhakar VK; Davis JR
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
Jewelewicz R
Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
[No Abstract] [Full Text] [Related]
35. Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor.
Burry KA; Schiller HS; Mills R; Harris B; Heinrichs L
Obstet Gynecol; 1978 Jul; 52(1 Suppl):19S-22S. PubMed ID: 683637
[TBL] [Abstract][Full Text] [Related]
36. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
37. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
Eftekhari N; Mohammadalizadeh S
Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
[TBL] [Abstract][Full Text] [Related]
39. Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
Merola B; Colao A; Caruso E; Sarnacchiaro F; Briganti F; Lancranjan I; Lombardi G; Schettini G
Gynecol Endocrinol; 1991 Dec; 5(4):267-76. PubMed ID: 1796748
[TBL] [Abstract][Full Text] [Related]
40. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Boulanger CM; Mashchak CA; Chang RJ
Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
